Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
(Adds details, background)Feb 3 (Reuters) - Britain's GSK forecast a dip in earnings this year as it grapples with COVID-19 disruptions and invests in its pipeline of new drugs, and said its plans to split into two businesses were on track.The wor...
Read more
(Sharecast News) - Shares of GlaxoSmithKline slumped on Wednesday after the pharmaceuticals giant said it expects 2021 earnings to decline, as it reported growth in revenues and profit for 2020.
Read more
LONDON MARKET MIDDAY: AstraZeneca And Glaxo Give Markets Vaccine Lift
Read moreTOP NEWS SUMMARY: Vaccine Hope From GlaxoSmithKline And AstraZeneca
Read more* Milan stocks rise on hopes of Draghi becoming next PM* Daimler jumps on plan to spin-off truck business* GSK slides; warns of bigger than expected fall in 2021 earnings (Updates to close)By Shreyashi Sanyal and Susan MathewFeb 3 (Reuters) - Itali...
Read more(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* GlaxoSmithKline slumps on COVID-19 vaccine development* Vodafone gains after earnings beat estimates* Glencore rises after maintaining 2021...
Read moreLONDON MARKET OPEN: Glaxo To Co-Develop Covid Vaccine; Vodafone Rises
Read moreLONDON BRIEFING: Glaxo Joins CureVac To Fight Covid-19 Variants
Read moreLONDON MARKET PRE-OPEN: GlaxoSmithKline, CureVac Team For Covid-19 Jab
Read more* 150 mln eur deal to develop next-generation vaccines* GSK to also help produce 100 mln doses of CureVac's vaccine* GSK has suffered setbacks in COVID-19 vaccine development (Adds background on vaccine technology)By Ludwig BurgerFRANKFURT, Feb 3 (...
Read more* 150 mln eur deal to develop next-generation vaccines* GSK to also help produce 100 mln doses of CureVac's vaccine* GSK has suffered setbacks in COVID-19 vaccine development (Adds background)FRANKFURT, Feb 3 (Reuters) - Britain's GlaxoSmithKline ...
Read moreFRANKFURT, Feb 3 (Reuters) - Britain's GlaxoSmithKline and German biotech firm CureVac struck a deal to develop next-generation vaccines against COVID-19 that target several variants in one product.In a joint statement on Wednesday, the partners s...
Read more(Sharecast News) - GlaxoSmithKline and CureVac on Wednesday announced a new venture to develop a vaccine targeting emerging variants of Covid-19 in one jab.
Read moreLONDON, Feb 2 (Reuters) - Britain recorded 1,449 deaths within 28 days of a positive test for COVID-19 on Tuesday, up from 406 a day earlier, with a further 16,840 cases of the disease, a decrease from a day earlier.Official data showed that 9.65 ...
Read moreLONDON, Feb 2 (Reuters) - Britain recorded 1,449 deaths within 28 days of a positive test for COVID-19 on Tuesday, up from 406 a day earlier, with a further 16,840 cases of the disease, a decrease from a day earlier.Official data showed that 9.65 ...
Read more
Last checked at